|
| Exchange Disseminated Time 17/05/2019 15:44:02 | | Jenburkt Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on May 28, 2019, inter alia, to take on record the audited financial results for the quarter and financial year ended on March 31, 2019 and to consider recommendation of Dividend, if any. |
|
|